3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Radiation Injuries
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Neoplasms
1
Nasopharyngeal Carcinoma
1
Myasthenia Gravis
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Hepatitis
1
Esophageal Stenosis
1
Esophageal Neoplasms
1
Chemical and Drug Induced Liver Injury
1
Brain Injuries
1
Interventions
Ursodeoxycholic Acid
1
Steroids
1
Spermine Synthase
1
Prednisone
1
Mycophenolic Acid
1
Methylprednisolone Hemisuccinate
1
Methylprednisolone
1
Liquid Biopsy
1
Clinical Protocols
1
Adrenal Cortex Hormones
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Hepatitis
×
Steroids
×
Clear all
NCT04810156
2022-12-14
I-HEP
Herlev Hospital
Phase 2
Unknown
60 enrolled